Effectiveness of exercise and physical activity in post-COVID-19 individuals.

Not Applicable

Recruiting

• Conditions: low step count; Dyspnea perception; pain perception; fatigue perception; anxiety; depression; poor quality of life; Infection - Other infectious diseases; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12622001538730
• Lead Sponsor: GÜLSAH BARGI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-13
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Adult individuals aged 18 and over who volunteered to participate in the research
• Individuals who can understand and answer surveys
• Compatible individuals who can perform exercises and have good cooperation.
• Individuals who were diagnosed with COVID-19 (individuals with a positive Polymerase Chain Reaction (PCR) test result, compatible with COVID-19 infection as a result of lung X-ray or lung tomography despite negative PCR test results) and discharged after recovery/home quarantine completed

Exclusion Criteria

• Individuals newly diagnosed with COVID-19, therefore in quarantine at home or receiving treatment in hospital
• Individuals with suspected COVID-19
• Pregnant women
• Individuals with serious psychiatric illness and therefore unable to adapt to exercise sessions
• Individuals with severe cognitive impairment
• Individuals with ongoing orthopedic, neurological, cardiovascular disorders and/or problems which are independent of COVID-19

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Daily step counts: Daily average step counts were recorded via a pedometer. All individuals were asked to carry their pedometers with them during the day and record to their diaries.[ Baseline, at the end of everyday during 4-week and at 4 weeks after baseline evaluation (primary timepoint)];Anxiety score obtained from Hospital Anxiety and Depression Scale (0-21)[ Baseline, at 4 weeks after baseline evaluation]

Secondary Outcome Measures

Name	Time	Method
Depression score obtained from Hospital Anxiety and Depression Scale (0-21)[ Baseline, at 4 weeks after baseline evaluation];Dyspnea perception evaluated using Medical Research Council Dyspnea Scale (0-4)[ Baseline, at 4 weeks after baseline evaluation];Pain score evaluated using Numarical Rating Scale (0-10)[ Baseline, at 4 weeks after baseline evaluation];Fatigue score evaluated using Numeraical Rating Scale (0-10)[ Baseline, at 4 weeks after baseline evaluation];Quality of life assessed using the SF-36 Quality of Life Questionnaire[ Baseline, at 4 weeks after baseline evaluation]